Paratek Pharmaceuticals, Inc.

Filing Type: S-4
Filing Date: 20081003

Documents

FORM S-4
S-4
SUBSIDIARIES OF THE REGISTRANT
EX-21.1
CONSENT OF ERNST & YOUNG LLP - NOVACEA, INC.
EX-23.1
CONSENT OF ERNST & YOUNG LLP - TRANSCEPT PHARMACEUTICALS, INC.
EX-23.2
CONSENT OF CHRISTOPHER B. EHRLICH TO BE NAMED AS A DIRECTOR
EX-99.6
CONSENT OF THOMAS D. KILEY TO BE NAMED AS A DIRECTOR
EX-99.7
CONSENT OF KATHLEEN D. LAPORTE TO BE NAMED AS A DIRECTOR
EX-99.8
CONSENT OF JAKE R. NUNN TO BE NAMED AS A DIRECTOR
EX-99.9
CONSENT OF GLENN A. OCLASSEN TO BE NAMED AS A DIRECTOR
EX-99.10
CONSENT OF G. KIRK RAAB TO BE NAMED AS A DIRECTOR
EX-99.11
CONSENT OF DANIEL K. TURNER III TO BE NAMED AS A DIRECTOR
EX-99.12